Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Condition:   Asthma Patients
Interventions:   Drug: AZD1981;   Drug: AZD1981;   Drug: Placebo
Sponsor:   AstraZeneca
Not yet recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days